CFCM / KNOWLEDGE
Knowledge
Connect the clinical question to the science.
Diseases & MRD
Start with a disease-centred curriculum pathway. Full Knowledge entity pages are the next stage.
B-cell Acute Lymphoblastic Leukaemia (B-ALL) ↗
Diagnosis, interpretation and MRD within the disease learning pathway.
ACADEMY OUTLINET-cell Acute Lymphoblastic Leukaemia (T-ALL) ↗
Diagnosis, interpretation and MRD within the disease learning pathway.
ACADEMY OUTLINEAcute Myeloid Leukaemia (AML) ↗
Diagnosis, interpretation and MRD within the disease learning pathway.
ACADEMY OUTLINEChronic Lymphocytic Leukaemia (CLL) ↗
Diagnosis, interpretation and MRD within the disease learning pathway.
ACADEMY OUTLINEB-cell lymphoproliferative disorders (B-LPD) ↗
Diagnosis, interpretation and MRD within the disease learning pathway.
ACADEMY OUTLINEPlasma cell neoplasms ↗
Diagnosis, interpretation and MRD within the disease learning pathway.
ACADEMY OUTLINEMyelodysplastic neoplasms / MDS ↗
Diagnosis, interpretation and MRD within the disease learning pathway.
Markers, panels & methods
Use the current articles and learning outlines while the structured marker and panel library is developed.
Validation & verification
Connect study design, performance concepts and practical reference material.
Validation curriculum ↗
Precision, reproducibility, linearity, AMR, stability, comparison and clinical performance.
REFERENCE HUBPractical reference library ↗
CLSI H62, verification, detection, quantification, carryover and reference intervals.
CLINICAL NOTESDetection & interpretation ↗
Explore concise Clinical Notes.